東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Metabolic effects of psychotropic drugs

Thakore, Jogin H., (1962-)

FindBook

Google Book

Amazon

博客來

Metabolic effects of psychotropic drugs

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Metabolic effects of psychotropic drugs/ volume editors, J. Thakore, B.E. Leonard.{me_controlnum}
其他作者:	Thakore, Jogin H.,
出版者:	Basel :S. Karger, : 2009,
面頁冊數:	1 online resource :ill. (some col.)
附註:	New insights into endocrine and obesity-related consequences of serious mental illness and their psychopharmacology
標題:	Psychotropic drugs - Side effects. -
電子資源:	http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=240013
ISBN:	9783805590020

Metabolic effects of psychotropic drugs
Metabolic effects of psychotropic drugs[electronic resource] /volume editors, J. Thakore, B.E. Leonard.{me_controlnum} - Basel :S. Karger,2009 - 1 online resource :ill. (some col.) - Modern trends in pharmacopsychiatry,v.261662-4505 ;. - Modern trends in pharmacopsychiatry ;v.26..

New insights into endocrine and obesity-related consequences of serious mental illness and their psychopharmacology

Includes bibliographical references and indexes.

Major depression and bipolar disorder are chronic enduring serious mental illnesses (SMI) with devastating effects on psychosocial functioning and may culminate in suicide. Over the past years, it has become apparent that subjects with these conditions can also develop the metabolic syndrome, which is a series of obesity-related physical conditions with an endocrine basis. This book brings together reviews that help put into context exactly why subjects with SMI develop obesity, prediabetic status, overt type 2 diabetes mellitus and related cardiovascular events. The relationship between prolactin and bone mineral density in subjects under medical treatment and the underlying dopaminergic mechanisms as well as the immunological changes occurring as an integral part of SMI and their effects on endocrine function are discussed and reviewed. Psychiatrists, diabetologists, cardiologists, family practitioners, public health physicians as well as basic science researchers will find valuable guidelines when screening for type 2 diabetes mellitus and cardiovascular disease in SMI.

ISBN: 9783805590020Subjects--Topical Terms:

535656
Psychotropic drugs
--Side effects.

LC Class. No.: RM315 / .M456 2009

Dewey Class. No.: 615/.788

National Library of Medicine Call No.: W1 / MO168P v.26 2009

Metabolic effects of psychotropic drugs
LDR:02158cmm a2200277 a 4500 001 1032434
003 SZ-BaSKA
005 20110603112133.0
006 m d
007 cr cn|||||||||
008 120420s2009 sz a ob 001 0 eng d
020 $a 9783805590020
035 $a 240013
040 $a szbaska
050 0 0 $a RM315 $b .M456 2009
050 4 $a RC483 $b .M6 v. 26
060 1 0 $a W1 $b MO168P v.26 2009
060 1 0 $a QV 77.2 $b M587 2009
082 0 0 $a 615/.788 $2 22
245 0 0 $a Metabolic effects of psychotropic drugs $h [electronic resource] / $c volume editors, J. Thakore, B.E. Leonard.{me_controlnum}
260 $a Basel : $b S. Karger, $c 2009
300 $a 1 online resource : $b ill. (some col.)
490 1 $a Modern trends in pharmacopsychiatry, $x 1662-4505 ; $v v.26
500 $a New insights into endocrine and obesity-related consequences of serious mental illness and their psychopharmacology
504 $a Includes bibliographical references and indexes.
520 $a Major depression and bipolar disorder are chronic enduring serious mental illnesses (SMI) with devastating effects on psychosocial functioning and may culminate in suicide. Over the past years, it has become apparent that subjects with these conditions can also develop the metabolic syndrome, which is a series of obesity-related physical conditions with an endocrine basis. This book brings together reviews that help put into context exactly why subjects with SMI develop obesity, prediabetic status, overt type 2 diabetes mellitus and related cardiovascular events. The relationship between prolactin and bone mineral density in subjects under medical treatment and the underlying dopaminergic mechanisms as well as the immunological changes occurring as an integral part of SMI and their effects on endocrine function are discussed and reviewed. Psychiatrists, diabetologists, cardiologists, family practitioners, public health physicians as well as basic science researchers will find valuable guidelines when screening for type 2 diabetes mellitus and cardiovascular disease in SMI.
650 0 $a Psychotropic drugs $x Side effects. $3 535656
650 0 $a Metabolic syndrome. $3 898683
650 0 $a Schizophrenia $x Chemotherapy $x Complications. $3 1360715
650 1 2 $a Psychotropic Drugs $x adverse effects. $3 535657
650 1 2 $a Psychotropic Drugs $x metabolism. $3 1360716
650 2 2 $a Mental Disorders $x drug therapy. $3 612937
700 1 $a Thakore, Jogin H., $d 1962- $3 1360712
700 1 $a Leonard, B. E. $3 1360713
830 0 $a Modern trends in pharmacopsychiatry ; $v v.26. $3 1360714
856 4 0 $u http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=240013